Showing results (51-60 of 3,787) with videos related to
Sort By:
Pageof 379
Oncoimmunology|July 30, 2016
A plant-expressed conjugate vaccine breaks CD4(+) tolerance and induces potent immunity against metastatic Her2(+) breast cancerWarayut Chotprakaikiat, Alex Allen, Duc Bui-Minh, et al.Oncoimmunology|July 30, 2016
ErratumOncoimmunology|July 3, 2015
CD4+ T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells-novel implications of CD4+ T cells in pancreatic cancer developmentLisa Goebel, Evelin Grage-Griebenow, Artur Gorys, et al.Oncoimmunology|July 3, 2015
Modulating gut immunity and neoplasia with oral cytokine adjuvantsHatice Ozbilge, Charles LeVea, Allen Y Chung, et al.Oncoimmunology|July 3, 2015
Trial Watch: Peptide-based anticancer vaccinesJonathan Pol, Norma Bloy, Aitziber Buqué, et al.Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8+ T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.Oncoimmunology|July 4, 2015
Depletion of regulatory T cells by targeting CC chemokine receptor type 4 with mogamulizumabXiao Ni, Timothy Langridge, Madeleine DuvicOncoimmunology|July 4, 2015
"In situ" vaccination for systemic effects in follicular lymphomaArne Kolstad, Johanna OlweusOncoimmunology|July 4, 2015
Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantationTomomi Toubai, Hou Guoqing, Corrine Rossi, et al.Oncoimmunology|July 4, 2015
Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cellsAnnie A Wu, Virginia Drake, Huai-Shiuan Huang, et al.Pageof 379